Effects of physostigmine on brain acetylcholine content and release.
D000109:Acetylcholine / Q000032:analysis / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002415:Cats; D002421:Caudate Nucleus / Q000032:analysis; D002540:Cerebral Cortex / Q000032:analysis; D005260:Female; D006624:Hippocampus / Q000032:analysis; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010830:Physostigmine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D008464:Mecamylamine; D010830:Physostigmine; D012601:Scopolamine; D010424:Pentobarbital; D000109:Acetylcholine